- Home
- XPON vs ATNF Comparison
XPON vs ATNF Comparison
Compare XPON & ATNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XPON
- ATNF
- Stock Information
- Founded
- XPON 2016
- ATNF 2016
- Country
- XPON United States
- ATNF United States
- Employees
- XPON N/A
- ATNF N/A
- Industry
- XPON Electronic Components
- ATNF Biotechnology: Pharmaceutical Preparations
- Sector
- XPON Technology
- ATNF Health Care
- Exchange
- XPON Nasdaq
- ATNF Nasdaq
- Market Cap
- XPON 2.3M
- ATNF 2.6M
- IPO Year
- XPON 2022
- ATNF N/A
- Fundamental
- Price
- XPON $2.27
- ATNF $2.20
- Analyst Decision
- XPON
- ATNF
- Analyst Count
- XPON 0
- ATNF 0
- Target Price
- XPON N/A
- ATNF N/A
- AVG Volume (30 Days)
- XPON 476.9K
- ATNF 147.9K
- Earning Date
- XPON 11-14-2024
- ATNF 11-14-2024
- Dividend Yield
- XPON N/A
- ATNF N/A
- EPS Growth
- XPON N/A
- ATNF N/A
- EPS
- XPON N/A
- ATNF N/A
- Revenue
- XPON $4,498,181.00
- ATNF N/A
- Revenue This Year
- XPON $0.68
- ATNF N/A
- Revenue Next Year
- XPON $29.04
- ATNF $54.15
- P/E Ratio
- XPON N/A
- ATNF N/A
- Revenue Growth
- XPON N/A
- ATNF N/A
- 52 Week Low
- XPON $2.09
- ATNF $1.16
- 52 Week High
- XPON $639.00
- ATNF $17.75
- Technical
- Relative Strength Index (RSI)
- XPON 33.19
- ATNF 38.87
- Support Level
- XPON $2.17
- ATNF $2.10
- Resistance Level
- XPON $2.83
- ATNF $2.58
- Average True Range (ATR)
- XPON 0.31
- ATNF 0.31
- MACD
- XPON 0.01
- ATNF -0.12
- Stochastic Oscillator
- XPON 5.32
- ATNF 6.67
About XPON Expion360 Inc.
Expion360 Inc is focused on the design, assembly, manufacturing and sales of lithium iron phosphate (LiFePO4) batteries and supporting accessories for recreational vehicles ("RV's") and marine applications with plans to expand into home energy storage products and industrial applications. Its product offerings include some of the minimal-footprint batteries in the RV & Marine industry.
About ATNF 180 Life Sciences Corp.
180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate, combination therapy.